跳至主要内容
临床试验/CTRI/2011/11/002108
CTRI/2011/11/002108招募中不适用

Evaluation of the role of Matrix metalloproteinases (MMPs) in Idiopathic Pulmonary Fibrosis (IPF) and assessment of clinicoradiological effect of Matrix metalloproteinases inhibition with Doxycycline.

Institute of Pulmocare Research1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年3月28日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
clinicoradiological with spirometric chanes.

研究概览

简要总结

Idiopathic pulmonary fibrosis is a problem of progressive fibrosis of the lung parenchyma without any apparent etiology leading to significant morbidity and premature mortality. The present treatment is limited to the use of corticosteroid and immunosuppressive agents with variable outcome and poor survival expectancy as 30 to 50% at 5 years after the diagnosis. In the process of fibrogenesis, there is a potential role of a class of enzyme called matrix metalloproteinases (MMPs). An imbalance of the MMPs and their tissue inhibitor (TIMPs) can lead to release of growth factors for fibroblast proliferation. Thus MMPs may play an important role in the pathogenesis of IPF and inhibition of MMPs could be a therapeutic target for the disease. The authors have experienced such therapeutic improvement in cases of IPF with doxycycline, an agent known for its MMPs inhibitory property with its use being accepted as MMPs inhibitor for periodontal disease by the FDA, xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /USA. The drug, doxycycline, has been well in use for a prolonged period of time in many conditions without problem of tolerance or toxicity.  It is a drug easily available in the market as an antibiotic for over three decades and has got certain established long term use too.xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /

The proposed project is to evaluate the role of MMPs in clinicoradiologically diagnosed IPF as per ATS-ERS guideline and also to assess the use of doxycycline in MMPs inhibition in the disease. The entire work can be simply and effectively done by way of observing the changes in different MMPs and TIMPs levels in BAL (broncho alveolar lavage) fluid of IPF patients before and following administration of doxycycline simultaneous to objective documentation of favourable effects on clinical, radiological and physiological status of the patients.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • •Informed written consent being given.
  • •Male and female patients aged 30 to70 years observing the major and minor criteria according to the ATS-ERS guideline.
  • •IPF diagnosed from pooled expert opinion on HRCT chest.
  • •No significant occupational history •FVC more than 40% of prediced •Non pregnant, non lactating woman.

排除标准

  • History of exacerbation in past 1 month •History of Doxy allergy •Having any obvious contraindication for Doxycycline •Unable to meet the demand of the protocol for any reason •Significant abnormality in liver or renal function •Feature of chronic congestive cardiac failure (supported by echocardiography) •Known case of IPF with CVD.

结局指标

主要结局

clinicoradiological with spirometric chanes.

时间窗: Two yrs

次要结局

  • change in Matrix metalloproteinases concentration in Bronchoalveolar lavage (BAF).(Two yrs.)

研究者

申办方类型
Other [Pulmonary research Institute recognized as Scientific and Industrial Research Organization]

研究点 (1)

Loading locations...

相似试验